{
    "organizations": [],
    "uuid": "57551712a4281ba149c4579f450c808808668f3f",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-acadia-pharma-q4-loss-per-share-05/brief-acadia-pharma-q4-loss-per-share-0-55-idUSASB0C7SR",
    "ord_in_thread": 0,
    "title": "BRIEF-Acadia Pharma Q4 Loss Per Share $0.55",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Feb 27 (Reuters) - Acadia Pharmaceuticals Inc:\n* ACADIA PHARMACEUTICALS REPORTS FOURTH QUARTER AND FULL YEAR 2017 FINANCIAL RESULTS\n* Q4 LOSS PER SHARE $0.55 * QTRLY TOTAL REVENUES $43.6 MILLION VERSUS $12.0 MILLION * Q4 EARNINGS PER SHARE VIEW $-0.58, REVENUE VIEW $44.3 MILLION -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:\n ",
    "published": "2018-02-28T05:55:00.000+02:00",
    "crawled": "2018-02-28T12:57:30.000+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "feb",
        "reuters",
        "acadia",
        "pharmaceutical",
        "inc",
        "acadia",
        "pharmaceutical",
        "report",
        "fourth",
        "quarter",
        "full",
        "year",
        "financial",
        "result",
        "q4",
        "loss",
        "per",
        "share",
        "qtrly",
        "total",
        "revenue",
        "million",
        "versus",
        "million",
        "q4",
        "earnings",
        "per",
        "share",
        "view",
        "revenue",
        "view",
        "million",
        "thomson",
        "reuters",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}